Literature DB >> 7822001

Subjects recovering from human ocular chlamydial infection have enhanced lymphoproliferative responses to chlamydial antigens compared with those of persistently diseased controls.

R L Bailey1, M J Holland, H C Whittle, D C Mabey.   

Abstract

Cell-mediated immune responses to chlamydial and common recall antigens were measured in 26 subjects whose clinical signs of trachoma persisted over 6 months of follow-up and in 21 subjects whose clinical signs resolved spontaneously over the same period. Seven-day lymphocyte proliferative responses to chlamydial but not common recall antigens were significantly greater in subjects whose disease resolved spontaneously. There was, however, no detectable difference between the two groups in gamma interferon levels in supernatants from lymphocyte cultures stimulated with these antigens. These results are consistent with the hypothesis that cell-mediated immune responses play an important role in the clearance of ocular chlamydial infection in humans.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7822001      PMCID: PMC173007          DOI: 10.1128/iai.63.2.389-392.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  The statistical analysis of data from immunoepidemiological studies.

Authors:  S Bennett; E M Riley
Journal:  J Immunol Methods       Date:  1992-02-05       Impact factor: 2.303

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Conjunctival scarring in trachoma is associated with depressed cell-mediated immune responses to chlamydial antigens.

Authors:  M J Holland; R L Bailey; L J Hayes; H C Whittle; D C Mabey
Journal:  J Infect Dis       Date:  1993-12       Impact factor: 5.226

4.  Resolution of chlamydial genital infection with antigen-specific T-lymphocyte lines.

Authors:  K H Ramsey; R G Rank
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

5.  Defining protective responses to pathogens: cytokine profiles in leprosy lesions.

Authors:  M Yamamura; K Uyemura; R J Deans; K Weinberg; T H Rea; B R Bloom; R L Modlin
Journal:  Science       Date:  1991-10-11       Impact factor: 47.728

6.  Monoclonal antibodies define genus-specific, species-specific, and cross-reactive epitopes of the chlamydial 60-kilodalton heat shock protein (hsp60): specific immunodetection and purification of chlamydial hsp60.

Authors:  Y Yuan; K Lyng; Y X Zhang; D D Rockey; R P Morrison
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

7.  Lymphocyte proliferative responses to chlamydial antigens in human chlamydial eye infections.

Authors:  D C Mabey; M J Holland; N D Viswalingam; B T Goh; S Estreich; A Macfarlane; H M Dockrell; J D Treharne
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

8.  Identification and characterization of T helper cell epitopes of the major outer membrane protein of Chlamydia trachomatis.

Authors:  H Su; R P Morrison; N G Watkins; H D Caldwell
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

9.  Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.

Authors:  M D Sadick; F P Heinzel; B J Holaday; R T Pu; R S Dawkins; R M Locksley
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

View more
  29 in total

1.  Cell-mediated immune response during primary Chlamydia pneumoniae infection.

Authors:  S Halme; J Latvala; R Karttunen; I Palatsi; P Saikku; H M Surcel
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

2.  T lymphocyte immunity in host defence against Chlamydia trachomatis and its implication for vaccine development.

Authors:  X Yang; R Brunham
Journal:  Can J Infect Dis       Date:  1998-03

3.  Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid.

Authors:  D J Conway; M J Holland; R L Bailey; A E Campbell; O S Mahdi; R Jennings; E Mbena; D C Mabey
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

4.  Urethral lymphocyte isolation in non-gonococcal urethritis.

Authors:  M Shahmanesh; P G Pandit; R Round
Journal:  Genitourin Med       Date:  1996-10

Review 5.  Development of a Chlamydia trachomatis T cell Vaccine.

Authors:  Karuna P Karunakaran; Hong Yu; Leonard J Foster; Robert C Brunham
Journal:  Hum Vaccin       Date:  2010-08-01

6.  Peripheral blood T cell proliferative response to chlamydial organisms in gonococcal and non-gonococcal urethritis and presumed pelvic inflammatory disease.

Authors:  M Shahmanesh; M Brunst; A Sukthankar; J H Pearce; J S Gaston
Journal:  Sex Transm Infect       Date:  1999-10       Impact factor: 3.519

7.  Chlamydia trachomatis (mouse pneumonitis strain) induces cardiovascular pathology following respiratory tract infection.

Authors:  Y Fan; S Wang; X Yang
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

8.  Active trachoma is associated with increased conjunctival expression of IL17A and profibrotic cytokines.

Authors:  Matthew J Burton; Athumani Ramadhani; Helen A Weiss; Victor Hu; Patrick Massae; Sarah E Burr; Wahida Shangali; Martin J Holland; David C W Mabey; Robin L Bailey
Journal:  Infect Immun       Date:  2011-09-12       Impact factor: 3.441

9.  Genetic profiling of dendritic cells exposed to live- or ultraviolet-irradiated Chlamydia muridarum reveals marked differences in CXC chemokine profiles.

Authors:  Michelle L Zaharik; Tarun Nayar; Rick White; Caixia Ma; Bruce A Vallance; Nadine Straka; Xiaozhou Jiang; Jose Rey-Ladino; Caixia Shen; Robert C Brunham
Journal:  Immunology       Date:  2006-10-31       Impact factor: 7.397

10.  Mucosal and peripheral immune responses to chlamydial heat shock proteins in women infected with Chlamydia trachomatis.

Authors:  T Agrawal; V Vats; S Salhan; A Mittal
Journal:  Clin Exp Immunol       Date:  2007-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.